University of Cambridge > > Computational and Systems Biology > Bioinformatics to support cancer therapeutics

Bioinformatics to support cancer therapeutics

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact so252.

AstraZeneca is a global pharmaceutical company that produced some of the most used cancer drugs and is now relocating to Cambridge. As the distance between industry and academic institutions is shrinking, AstraZeneca is looking to promote more interaction and foster new research collaborations. We will give an overview of how AstraZeneca is utilizing bioinformatics to help develop the next generation of drugs to treat cancer. As computational biologists with both industry and academia experience, we will also compare research environments in the two sectors.

This talk is part of the Computational and Systems Biology series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.


© 2006-2023, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity